SOD2 may promote the progression of ovarian cancer; thus, it is suggested that inhibiting the expression of SOD2 may hinder the development and invasion of ovarian cancer by increasing the level of ROS that oxidatively damages ovarian cancer cells [128]. Here, SOD2 is linked to ovarian carcinoma.